Electrochemical Oxygen Concepts
San Antonio, US · Founded 2007 · Delaware corporation
Founders & leadership
LM
Lee M. KelleyExecutive
JM
Joseph MoffettNamed on SEC filing
LP
L. Peter SmithNamed on SEC filing
JD
James DeYoungNamed on SEC filing
DJ
David J. KazynskiNamed on SEC filing
MQ
Mark Q. NiederauerNamed on SEC filing
JW
Jim W. PhillipsNamed on SEC filing
MC
Michael C. WellsNamed on SEC filing
DL
Dr. Lanny GearyNamed on SEC filing
Board
JW
James W. DeYoungBoard director
JP
Jim PhillipsBoard director
Reported raises · per SEC filings
Form D private placements$17.7M disclosed across 9 rounds · 2011–2022
▶$370KraisedNov 2022 · 7 investors · BiotechnologyRule 506(b)
▶$370KraisedNov 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James W. DeYoungDirector
- James WalshDirector
- David J. KazynskiDirector
- L. Peter SmithDirector
- Mark Q. NiederauerExecutive Officer, Director
- Offering amount
- $370K
- Amount sold
- $370K
- Minimum investment
- $15K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJan 2021 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim WalshDirector
- L. Peter SmithDirector
- Joseph MoffettExecutive Officer, Director
- James W. DeYoungDirector
- David J. KazynskiDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedJan 2021 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MoffettExecutive Officer, Director
- James W. DeYoungDirector
- David J. KazynskiDirector
- Jim WalshDirector
- L. Peter SmithDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MoffettExecutive Officer, Director
- L. Peter SmithDirector
- James W. DeYoungDirector
- David J. KazynskiDirector
- Jim WalshDirector
- Offering amount
- $500K
- Amount sold
- $500K
- Minimum investment
- $500K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 1 investors · BiotechnologyRule 506(b)
▶$2.3MraisedAug 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MoffettExecutive Officer, Director
- Jim WalshDirector
- L. Peter SmithDirector
- David J. KazynskiDirector
- James W. DeYoungDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Minimum investment
- $2.3M
- Proceeds to insiders
- $60K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.7MraisedMay 2018 · 16 investors · BiotechnologyRule 506(b)
▶$8.7MraisedMay 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MoffettExecutive Officer, Director
- L. Peter SmithDirector
- James W. DeYoungDirector
- David J. KazynskiDirector
- Jim WalshDirector
- Offering amount
- $8.7M
- Amount sold
- $8.7M
- Sales commissions
- $50K
- Proceeds to insiders
- $60K
- Placement agents
- Gordian Investments, LLC
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$907.5KraisedJul 2017 · 2 investors · BiotechnologyRule 506(b)
▶$907.5KraisedJul 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph MoffettExecutive Officer, Director
- L. Peter SmithDirector
- James DeYoungDirector
- David J. KazynskiDirector
- Mark Q. NiederauerExecutive Officer
- Jim W. PhillipsDirector
- Michael C. WellsDirector
- Dr. Lanny GearyDirector
- Offering amount
- $907.5K
- Amount sold
- $907.5K
- Minimum investment
- $100K
- Sales commissions
- $18.1K
- Proceeds to insiders
- $60K
- Placement agents
- Gordian Investments, LLC
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$70KraisedApr 2014 · 2 investors · BiotechnologyRule 506(b)
▶$70KraisedApr 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael C. WellsExecutive Officer, Director
- Mark Q. NiederauerExecutive Officer
- L. Peter SmithDirector
- James W. DeYoungDirector
- Jim PhillipsDirector
- David J. KazynskiDirector
- Lee M. KelleyExecutive Officer
- Offering amount
- $70K
- Amount sold
- $70K
- Minimum investment
- $20K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Electrochemical Oxygen Concepts raised?
- Electrochemical Oxygen Concepts has disclosed $17.7M raised across 9 rounds.
- Where is Electrochemical Oxygen Concepts headquartered?
- Electrochemical Oxygen Concepts is headquartered in San Antonio, US.